Get the Stockscreener App
265.53
0.45%
-1.20
After Hours:
265.19
-0.34
-0.13%
Overview
News
Price History
Option Chain
Financials
Why JNJ Down?
Discussions
Forecast
Stock Split
Dividend History
Johnson Johnson stock is traded at $265.53, with a volume of 5.82M.
It is down -0.45% in the last 24 hours and up +2.72% over the past month.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
See More
Previous Close:
$266.73
Open:
$268.5
24h Volume:
5.82M
Relative Volume:
0.73
Market Cap:
$639.90B
Revenue:
$97.93B
Net Income/Loss:
$21.04B
P/E Ratio:
30.78
EPS:
8.6278
Net Cash Flow:
$17.80B
1W Performance:
+3.87%
1M Performance:
+2.72%
6M Performance:
+16.82%
1Y Performance:
+57.95%
1-Day Range:
$264.79
$269.34
1-Week Range:
$254.42
$274.90
52-Week Range:
$164.23
$274.90
Johnson Johnson Stock (JNJ) Company Profile
Name
Johnson Johnson
Sector
Industry
Phone
732-524-2455
Address
ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ
Compare JNJ vs LLY, ABBV, MRK, NVS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
JNJ
Johnson Johnson
|
265.53 | 640.91B | 97.93B | 21.04B | 17.80B | 8.6278 |
LLY
Lilly Eli Co
|
1,210.02 | 1.07T | 72.25B | 25.28B | 10.37B | 27.78 |
ABBV
Abbvie Inc
|
263.30 | 453.91B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
130.36 | 322.95B | 65.51B | 8.93B | 14.12B | 3.5532 |
NVS
Novartis Ag Adr
|
158.83 | 296.72B | 54.66B | 13.58B | 16.05B | 7.0171 |
Johnson Johnson Stock (JNJ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-13-26 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Apr-08-26 | Resumed | TD Cowen | Buy |
| Jan-28-26 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-13-25 | Initiated | Scotiabank | Sector Outperform |
| Oct-20-25 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Oct-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-23-25 | Upgrade | Guggenheim | Neutral → Buy |
| Jul-23-25 | Upgrade | Erste Group | Hold → Buy |
| May-13-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-10-24 | Resumed | BofA Securities | Neutral |
| Nov-15-24 | Initiated | Wolfe Research | Outperform |
| Jul-23-24 | Downgrade | Daiwa Securities | Outperform → Neutral |
| May-30-24 | Resumed | Goldman | Neutral |
| Apr-18-24 | Upgrade | HSBC Securities | Hold → Buy |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-01-23 | Upgrade | UBS | Neutral → Buy |
| Oct-05-23 | Initiated | RBC Capital Mkts | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Resumed | Citigroup | Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-01-23 | Initiated | Guggenheim | Neutral |
| Nov-18-22 | Initiated | Credit Suisse | Neutral |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-14-22 | Reiterated | BofA Securities | Neutral |
| Jun-22-22 | Initiated | Daiwa Securities | Outperform |
| May-23-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-16-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-17-21 | Initiated | Goldman | Neutral |
| Dec-15-21 | Reiterated | Citigroup | Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-28-21 | Resumed | Morgan Stanley | Overweight |
| Apr-28-20 | Downgrade | UBS | Buy → Neutral |
| Apr-22-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Dec-19-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-17-19 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-20-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-16-19 | Upgrade | Atlantic Equities | Underweight → Neutral |
| Oct-11-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jul-12-19 | Resumed | Credit Suisse | Outperform |
| May-28-19 | Initiated | Goldman | Buy |
| Jan-23-19 | Reiterated | Barclays | Equal Weight |
| Jul-12-18 | Upgrade | Goldman | Sell → Neutral |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-23-18 | Reiterated | Citigroup | Neutral |
| Apr-18-18 | Reiterated | Stifel | Hold |
| Jan-24-18 | Reiterated | Stifel | Hold |
| Jan-12-18 | Reiterated | Wells Fargo | Outperform |
| Jan-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-18-17 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-18-17 | Reiterated | Stifel | Hold |
View All
Johnson Johnson Stock (JNJ) Latest News
Stacey Dales on what to expect from Year 2 of Ben Johnson | 'GMFB' - NFL.com
Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fightABC News - ABC News - Breaking News, Latest News and Videos
Johnson & Johnson Introduces MONARCH™ Platform to the Middle East - Johnson & Johnson
Vanguard Health Care ETF Outperforms VanEck Biotech on Returns, Yield, and Fees - The Motley Fool
Stocks making the biggest moves premarket: Coca-Cola, Sherwin-Williams, Johnson & Johnson & more - CNBC
Official Site of the National Football League - NFL.com
US pharma giant to pay out $7.9 billion over baby powder lawsuits - ABC News & Headlines – Australian Broadcasting Corporation
Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit - The Guardian
Johnson & Johnson to pay $5.5bn to settle US talcum powder lawsuit - Financial Times
Johnson & Johnson offers up to $5.5bn to settle baby powder lawsuits - BBC
Johnson & Johnson Agrees to Pay $5.5 Billion to Settle Talc Lawsuits - WSJ
J&J offers $5.5bn settlement in lawsuits claiming talc link to cancer - Al Jazeera
Raiders sign 3 players, waive 3 - Raiders.com
Johnson & Johnson announces $5.5 billion settlement of talc lawsuits - Reuters
Johnson & Johnson Settles 76,000 Talcum Powder Lawsuits for $5.5B - Law.com
Trump boosts Rogers, James and other Michigan Republicans at Milford rally - Michigan Advance
Fairgoers flock to Johnson County Fair amidst heatwave - KCRG
Alaska Legislature opens third gasline special session with no fanfare and even less optimism - Alaska Beacon
Johnson & Johnson (JNJ) Raised Its Outlook. Is It the Better Healthcare Stock to Own After Earnings? - Yahoo Finance
Titans Sign DB Nazeeh Johnson - Tennessee Titans
Wilson Sonsini Advises Firefly Bio on $1 Billion Acquisition by Johnson & Johnson - Wilson Sonsini
OhioHealth Hardin Memorial Awards 22 Mary Lou Johnson Scholarships - OhioHealth Newsroom
Plas Johnson obituary - The Guardian
Exclusive First Look: Dakota Johnson and Ellen Burstyn Play Marilyn Monroe - Vanity Fair
President Trump Loves Johnson & Johnson (JNJ), But Insiders Are Selling - Yahoo Finance
Obituary for James E. Johnson - Gude Mortuary
Chicago renters’ rights are at stake in dueling City Hall proposals - WBEZ Chicago
Is Johnson & Johnson Stock a Buy After Its $2 Billion TREMFYA Quarter? - TIKR.com
Zacks Investment Ideas feature highlights: General Motors, Abbott Laboratories and Johnson & Johnson - Yahoo Finance
New Minnesota State Fair award will honor late ‘Blue Ribbon Baker’ Marjorie Johnson - MPR News
Johnson & Johnson Now Leads Its Pitch With An Oncology Bet - Trefis
Prof David Johnson honoured with lifetime achievement award - Metro South Health
Jonathan Ornelas singles on a line drive to right fielder Bryce Johnson. Drew Swift scores. Darell Hernaiz to 3rd. - MLB.com
Paris Johnson Jr. Media Availability | Arizona Cardinals Training Camp | July 24, 2026 - Arizona Cardinals
GOP senator ahead of Fauci testimony: ‘I don’t expect to get much out of him’ - The Hill
Ivan Johnson homers (10) on a fly ball to left field. - MLB.com
Jimmie Johnson's NASCAR car number announced for 2027 Daytona 500, his last race - The Tennessean
Jimmie Johnson to drive iconic No. 48 in final Daytona 500 start - NASCAR.com
Emmett Johnson: 'I Take Pride in Helping the Team in all Phases' | Press Conference 7/26 - Chiefs.com
Jimmie Johnson to return to No. 48 car number for final NASCAR Cup Series start at the 2027 DAYTONA 500 - Hendrick Motorsports
In case you missed it: President Oaks speaks on families, President Johnson is parade marshal, plus 7 more stories - Church News
Fans rally around Boris Johnson, 62, as fears expressed - oxfordtimes.co.uk
Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson? - The Motley Fool
James S. Johnson Obituary Jul 26, 2026 - Mueller-Bies Funeral Homes
Should J&J’s Oncology and MedTech Breakthroughs Prompt a Fresh Look From Johnson & Johnson (JNJ) Investors? - simplywall.st
Sheerlean Viola Johnson Burns obituary - Donald K. Walker Funeral Directors
Bjorn Johnson Ball to Angel Cepeda - MLB.com
Multi-state search continues for woman accused of killing man, leaving him in shallow grave - Upper Michigan's Source
Photos: Juwan Johnson hosts Girls Flag Football at New Orleans School of Cooking - New Orleans Saints | NewOrleansSaints.com
SDCC 2026: The Midnight Universe Looms Over Marvel Heroes with Issue #2 Reveals - Marvel.com
Obituary for Shirley Ann (Jepsen) Johnson - Plainville Funeral Home
Johnson Johnson Stock (JNJ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):